Physician profile
Ryan Minier
NPI 1992324941
$809.38
in general payments reported to CMS, 2019-2025
11 companies · $71.15 in 2025
The $71.15 reported for 2025 was less than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $314 · 2022: $325 · 2023: $17.10 · 2024: $82.63 · 2025: $71.15.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $171.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $170.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, INC. | $383.67 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $124.82 | 2022 | |
| Abbvie INC. | $50.00 | 2021 | |
| Merck Sharp & Dohme LLC | $48.52 | 2024-2025 | Vaxneuvance, Gardasil 9 |
| Organon LLC | $37.60 | 2022 | |
| Exact Sciences Corporation | $34.73 | 2023-2025 | Cologuard Collection Kit |
| Sanofi Pasteur INC. | $31.76 | 2022-2024 | |
| Janssen Pharmaceuticals, INC | $29.25 | 2024 | Invega Trinza, Invega Sustenna |
| Ironshore Pharmaceuticals INC. | $24.44 | 2022 | |
| Otsuka America Pharmaceutical, INC. | $23.56 | 2024 | Rexulti |
| Alkermes, INC. | $21.03 | 2025 | Vivitrol |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Minier listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.